Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery

NCT00706667 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

75

Enrollment

OTHER

Sponsor class

Stopped Not being able to recuit sufficient patients due to a lack of complience

Conditions

Iron Deficiency Anemia

Interventions

DRUG: Ferinject ®

Sponsor

University of Zurich

Collaborators

[object Object]